AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for NMDAR Autoimmune Encephalitis

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism NCT06079294NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: FDG PET Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) NCT06584045NA1 site📍 Wuhan Tongji Hospital · Tests: Calculus bovis sativus (CBS) Long-term Impact of NMDAR Encephalitis, Level 3 NCT07158229n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Questionnaires A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease NCT07093333Phase 21 site📍 Seoul Arialys Australia Pty Ltd · Tests: ART5803, ART5803-Cohort D Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis NCT06510283Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Taitacept Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis NCT03993262Phase 217 sites📍 München📍 Würzburg📍 Jena Jena University Hospital · Tests: Bortezomib, Placebo Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis NCT06867991Phase 32 sites📍 Zhengzhou📍 Changzhou The First People's Hospital of Changzhou · Tests: Ofatumumab combined with daratumumab, Ofatumumab, Repeated intravenous immunoglobulin/plasma exchange therapy Medium-term Effects of Treatments in Autoimmune Encephalitis NCT07133113n/a1 site📍 Bron Hospices Civils de Lyon · Tests: We aim to assess the clinical response to the treatment initiation protocols most commonly used in autoimmune encephali… Efgartigimod in Anti-NMDA Receptor Encephalitis. NCT07822776Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Efgartigimod Alfa Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) NCT05017142n/a13 sites📍 Aarau📍 Sankt Gallen📍 Lausanne University of Bern The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis NCT04372615Phase 239 sites📍 Birmingham📍 Phoenix📍 Scottsdale University of Utah · Tests: Inebilizumab, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy